Intuniv XR (2017-04-21)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| AF6131D | - Recalling Firm
- Shire Pharma Canada ULC
- 2250 Alfred-Nobel Blvd, suite 500
- Saint-Laurent
- H4S 2C9
- Quebec
- CANADA
- Marketing Authorization Holder
- Shire Pharma Canada ULC
- 2250 Alfred-Nobel Blvd, suite 500
- Saint-Laurent
- H4S 2C9
- Quebec
- CANADA
| Intuniv XR | Tablet (Extended-Release) | DIN 02409119 | 2 mg Guanfacine (Guanfacine hydrochloride) |
Affected lot may be associated with adverse reaction that may be linked to potential Digoxin contamination.
Healthcare professionals across Canada